top of page

Improving cancer treatment through rapid, cost-effective drug development



Oxilio is a pioneering pharmaceutical drug development company working to identify, repurpose and commercialise existing drugs to address unmet needs in cancer therapy.


We find new uses for old drugs, a proven approach that involves less time, cost and risk to bring a drug to the marketplace.

bottom of page